Gardasil's Use in Men Studied

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p57
Trade Publication
The article presents a study published in the "New England Journal of Medicine" which found Gardasil to be 89% effective against human papillomavirus (HPV)-related genital warts in men ages 16-26, according to Merck & Co. Inc.


Related Articles

  • Private Matters. Eastman, Peggy // Self;Mar99, Vol. 21 Issue 3, p112 

    Focuses on genital warts. Number of people in the United States who are infected with the human papillomavirus (HPV); Treatments for removing genital warts; Information on Aldara, a prescription cream for genital warts.

  • Successful Treatment of Extensive Condyloma Acuminata of the Inguinal Area and Thigh with Topical Imiquimod Cream. Weinberg, Jeffrey M.; Stewart, Allison; Stern, Jerry O. // Acta Dermato-Venereologica;Jan/Feb2001, Vol. 81 Issue 1, p76 

    Describes a patient with extensive condyloma acuminata involving the groin and thigh area who had a dramatic response to topical imiquimod cream. Extensive involvement of the right inguinal area and thigh with verruceous papules; Usefulness of imiquimod as primary or adjunct therapy in the...

  • Genital Warts and Their Treatment. Buetner, Karl R.; Wiley, Dorothy J.; Douglas, John M.; Tyring, Stephen K.; Fife, Kenneth; Trofatter, Kenneth; Stone, Katherine M. // Clinical Infectious Diseases;1/1/1999 Supplement 1, Vol. 28, pS37 

    Focuses on the available treatments and management methods for patients with external genital warts (EGW) and other topics. Human papillovirus screening issues as they relate to patients with EGW and their sex partners; Patient-applied treatments; Provider administered treatments; Alternative...

  • Early HPV vaccination significantly reduced condylomata incidence.  // Hem/Onc Today;6/10/2013, Vol. 14 Issue 11, p3 

    The article explores the study conducted by Karolinska Institutet research associate Lisen Arnheim-Dahlström and her colleagues that revealed a significant reduction in the incidence of condylomata acuminata among women who received initial vaccinations for HPV when they were 14 years old or...

  • Issues in the management of human papillomavirus genital ... Verdon, Mary E. // American Family Physician;4/1/1997, Vol. 55 Issue 5, p1813 

    Discusses information about the human pappillomavirus (HPV) which infects epithelial cells at a variety of anatomic sites. Clinical manifestations of genital HPV; Diagnosis and detection of HPV; Types of HPV associated with clinical lesions; Treatment of a genital warts.

  • HPV vax strategy would be well worth it in Mexico.  // PharmacoEconomics & Outcomes News;1/12/2008, Issue 544, p6 

    The article reports on a study which found that a quadrivalent human papillomavirus (HPV) vaccine programme could be a highly effective and cost efficient strategy for declining the incidence of cervical cancer and genital warts in Mexico. The starategies for HPV vaccination are mentioned. It...

  • Simultaneous determination of preservatives benzyl alcohol, methyl paraben and propyl paraben used in Imiquimod cream using RP-HPLC-PDA. Bachute, Madhusudhan T.; Turwale, Shankar L.; Dwivedi, Rajesh K. // Journal of Pharmacy Research;2012, Vol. 5 Issue 6, p3449 

    A simple, rapid, accurate and precise reverse phase isocratic HPLC method has been developed for the simultaneous determination of preservatives benzyl alcohol, methyl paraben and propyl paraben used in Imiquimod cream which is widely used for treatment of genital warts, known as Human Papilloma...

  • Low HPV transmission risk associated with genital wart removal.  // Infectious Disease News;Apr2014, Vol. 27 Issue 4, p44 

    The article discusses a study, led by Kristian Kofoed and presented at the American Academy of Dermatology's 2014 conference in Denver, Colorado, on the low risk for human papillomavirus (HPV) transmission in health care workers during the treatment of genital warts or cervical dysplasia.

  • Initial trials examine HPV wart therapies. Guttman, Cheryl // Dermatology Times;Sep98, Vol. 19 Issue 9, p3 

    Focuses on clinical trials that may lead to treatment for patients with cutaneous or genital warts caused by human papillomavirus (HPV). Information about the phases of the clinical trials; How the PEN203 antiviral agent was designed; Effectiveness offered by interferon in treating genital...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics